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OBJECTIVES: We aimed to determine the characteristics affecting insulin resistance in non-obese middle-aged 
adults in a rural community. 
METHODS: A total of 1,270 non-diabetic adults aged between 40 and 64 years old with body mass index 
(BMI) less than 25 kg/m
2 were analyzed. Subjects with insulin resistance were defined as those who had the 
highest quartile value of the homeostasis model assessment of insulin resistance (HOMA-IR) in a non-diabetic 
population. 
RESULTS: A total of 217 subjects (20.6%) had insulin resistance. Prevalence of metabolic syndrome was sig-
nificantly higher in insulin-resistant subjects in both men (29.3% vs. 10.3%) and women (34.1% vs. 15.6%). 
Among metabolic syndrome components, elevated waist circumference and elevated triglyceride were higher 
in insulin-resistant subjects in both genders. After being controlled for socioeconomic status and lifestyle relat-
ed covariates, the association between insulin resistance and BMI was statistically significant in the category of 
23.0-24.9 kg/m
2 in men (adjusted OR, 4.63; 95% confidence interval [95%CI], 1.77-12.15) using the category 
of 18.5-20.9 kg/m
2 as a reference. In addition, the association between insulin resistance and abdominal obesi-
ty was statistically significant only for men (adjusted OR, 2.57; 95%CI, 1.29-5.11). 
CONCLUSION: Insulin resistance appears to be highly associated with high BMI and abdominal obesity, even 
in non-obese, non-diabetic middle-aged men.
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INTRODUCTION
Obesity is a risk factor for various types of metabolic disease 
including type 2 diabetes and hypertension [1-3], and it has 
been considered as a major health issue in many countries [4]. 
One of the diagnostic indicators for obesity, body mass index 
(BMI), has a simplified measurement method. In addition, it 
has been known as a useful tool for predicting risks of develop-
ing various types of cardiovascular disease [5]. However, a 
BMI-based diagnosis of obesity cannot include all the scope of 
obesity. For instance, in all the patients who were diagnosed as 
obese, there was a lack of the collection of metabolic risk fac-
tors associated with cardiovascular disease. It has also been re-
ported that the people in the non-obesity range did not always 
show healthy metabolic status [6]. 
Of these concepts, patients who were not apparently obese, 
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i.e., had a normal profile based on BMI criteria but had obesity-
related metabolic abnormalities, were defined as “Metabolically 
Obese Normal Weight (MONW)” by Ruderman et al. [7]. It 
was hypothesized that these subjects showed hyperinsulinemia 
or insulin resistance, acquired a metabolically obese status and 
had a higher degree of risk of developing cardiovascular dis-
ease [8]. In the MONW group, as compared with the control 
group, the incidence of abdominal obesity and visceral fat was 
relatively higher. With the presentation of hypercholesterol-
emia, low high-density lipoproteinemia, hypertriglyceridemia 
and high blood pressure, risks of developing cardiovascular dis-
ease have been reported to be relatively higher [9,10]. In addi-
tion, a prospective cohort study shows that higher risks of de-
veloping type 2 diabetes and cardiovascular disease have been 
found in the MONW group as compared with subjects who were 
metabolically healthy. These results were also shown to be rela-
tively higher following a comparison with obese subjects who 
were metabolically healthy [11]. 
Through the active identification, with the use of such inter-
ventions as diet, exercise therapy and drug treatments, the ne-
cessity for the delay of disease progression has been proposed 
[12]. For the appropriate management of these patients, their 
characteristics should first be clarified. In Korea, however, there 
are few studies about these issues. Other than small sample siz-
es in most of the pre-existing studies, there were also limitations 
that socioeconomic status and lifestyle-related characteristics 
were not considered.
The purpose of this study was to determine the characteristics 
of clinical, socioeconomic, and lifestyle features affecting the in-
sulin resistance in non-obese middle-aged adults who were re-
siding in a rural community. 
MATERIALS AND METHODS
Subjects
The current study was conducted in adults aged 40 years or 
older who were residing in rural districts of Chungju area be-
tween 2005 and 2006 from February to April in each year. Sub-
ject areas were stratified into 29 rural health subcenters and 
health care posts. Using a stratified random cluster sampling in 
which towns belonging to each district were classified as a clus-
ter, 166 towns were selected and 6,388 subjects participated in 
the current study [13-15]. Of them, based on the BMI, 1,679 
non-obese (18.5-24.9 kg/m
2) adults aged between 40 and 64 
years (males: 761 and females: 918) were enrolled in the cur-
rent study. After excluding 409 subjects (those with a past his-
tory of cardiovascular diseases, diabetes mellitus or hyperten-
sion, and those whose fasting glucose and fasting insulin were 
dropped out), 1,270 subjects (males: 598 and females: 672) were 
finally selected as a study population. The current study was ap-
proved by The Institutional Review Board (IRB) of The Catholic 
University of Korea, the Kangnam St. Mary’s Hospital.
Measurements
A questionnaire survey was performed to examine lifestyle-
related characteristics such as smoking, drinking and exercise 
habit. The status of smoking and drinking alcohol were exam-
ined. The type of exercise, the mean frequency of exercise and 
exercise time were examined. Sociodemographic variables in-
clude the educational status, occupation, the total monthly in-
come, and living with spouse of the subjects. Eating over 20 
kinds of the food items including meat, fish, vegetable, fruit and 
rice in a day was defined as a balanced diet [16].
Using the standardized methods, the height, weight, and waist 
and the hip were measured. The height, waist and hip were mea-
sured at a unit of 0.1 cm. The weight was measured at a unit of 
0.1 kg. BMI was calculated using the formula weight (kg)/height 
(m
2). The systolic blood pressure and diastolic blood pressure 
were measured using a sphygmomanometer in a sitting posi-
tion after a more than 10-minute stabilization prior to blood 
sampling. In the right upper arm, the blood pressure was mea-
sured twice. Then, in cases in which the difference in the dia-
stolic pressures was smaller than 5 mmHg, the average value of 
two measurements was obtained.
Prior to blood sampling, all subjects were fasted over 12 hours 
and blood analysis was performed in a central laboratory. Total 
serum cholesterol and triglyceride were measured using an en-
zymatic calorimetric test. High-density lipoprotein (HDL) cho-
lesterol was measured using a selective inhibition method, and 
low-density lipoprotein (LDL) cholesterol was calculated using 
the Friedewald formula [17]. Following the blood sampling, a 
sodium fluoride tube was used to store and transfer fasting glu-
cose. It was measured using the hexokinase method. Fasting se-
rum insulin was measured using a Radiommunoassay kit (Dain-
abot, Japan).
In the current study, of those whose BMI was within a normal 
range (18.5-24.9 kg/m
2), to define the group where there was a 
insulin resistance, insulin resistance was assessed using the ho-
meostasis model assessment of insulin resistance (HOMA-IR). 
Of 6,388 adults aged 40 years or older who participated in the 
current study, excluding patients with diabetes mellitus, 5,779 
were used to establish a critical point which corresponds to the 
highest quartile number of HOMA-IR in each year (2005, 1.69; 
2006, 1.74). Of subjects who were enrolled in the current study, 
those who corresponded to more than a critical point were con-
sidered to have an insulin resistance. The formula for calculating 
HOMA-IR was as follows: 
(HOMA-IR=fasting insulin (µU/mL)×fasting glucose (mmol/
L)/22.5) [18].3
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A definition of metabolic syndrome was made based on the 
criteria of modified NCEP-ATP III (Third report of National 
Cholesterol Education Program Expert panel on detection, eval-
uation and treatment of high blood cholesterol in adults-Adults 
Treatment Panel III, 2001) [19] using the criteria of abdominal 
obesity based on the Korean Society for the Study of Obesity 
diagnostic criteria of male ≥90 cm and female ≥85 cm [20].
Statistical analysis
To compare the characteristics between insulin-resistant sub-
jects and the other group by gender, a chi-square test for cate-
gorical variables and student’s t-test for continuous variables 
were applied. For parameters showing non-normal distributions 
(triglycerides, fasting glucose, fasting insulin, and HOMA-IR), 
Wilcoxon rank sum test was performed. To examine the factors 
associated with insulin resistance in the non-obese group, a mul-
tiple logistic regression was performed by gender. Variables of 
p-value <0.25 in the univariate test were selected as candidates 
for the multivariate model along with age. All two-tailed p-val-
ues of 0.05 were regarded as indicating statistical significance. 
All the statistical analyses were performed using SAS version 
9.1 (SAS Inc., Cary, NC, USA).
RESULTS
A comparison of the general and lifestyle-related 
characteristics between the subjects with insulin 
resistance and without insulin resistance
A total of 82 men (13.7%) and 135 women (20.1%) were 
insulin-resistant subjects. The proportion of insulin-resistant sub-
jects was higher in subjects with over nine years of education 
(p=0.042) for men, and lower in farmers for women (p=0.041) 
(Table 1).
Table 1. General and lifestyle-related characteristics of the subjects with insulin resistance and without insulin resistance by gender
Variables
Men Women
With insulin resistance 
(n=82)
Without insulin  
resistance (n=516)
p
With insulin resistance 
(n=135)
Without insulin  
resistance (n=537)
p
Age  54.5±6.7 54.8±6.9 0.675 54.3±7.2 53.5±7.1 0.241
Family history of type 2 diabetes
Yes 7 (13.7) 44 (86.3) 0.998 19 (23.5) 62 (76.5)  0.420
No 75 (13.7) 472 (86.3) 116 (19.6)  475 (80.4)
Education
<9 51 (11.9) 378 (88.1) 0.042 117 (20.6) 452 (79.4) 0.499
≥10 30 (18.3) 134 (81.7) 18 (17.7) 84 (82.4)
Occupation
Farmer 66 (14.2) 398 (85.8) 0.498 71 (17.5) 334 (82.5) 0.041
Others 16 (11.9) 118 (88.1) 64 (24.0) 203 (76.0)
Living with spouse
Yes 41 (15.4) 226 (84.7) 0.294 60 (18.3) 267 (81.7) 0.273
No 41 (12.4) 290 (87.6) 75 (21.7) 270 (78.3)
Monthly expense (10,000 won)
<50 17 (16.5) 86 (83.5) 0.598 28 (21.7) 101 (78.3) 0.408
50-99 20 (11.2) 158 (88.8) 46 (22.3) 160 (77.7)
100-149 24 (13.4) 155 (86.6) 33 (20.6) 127 (79.4)
≥150 21 (15.2) 117 (84.8) 28 (15.8) 149 (84.2)
Drinking alcohol
Non-drinker 29 (15.9) 153 (84.1) 0.275 105 (21.4) 385 (78.6) 0.195
Ever-drinker 51 (12.6) 243 (87.4) 28 (16.8) 139 (83.2)
Smoking 
Non-smoker 18 (13.4) 116 (86.6) 0.901 134 (20.6) 516 (79.4) 0.310
Ever-smoker 64 (13.9) 398 (86.1) 1 (5.9) 16 (94.1)
Balanced diet 
Yes 48 (13.4) 311 (86.6) 0.766 79 (22.2) 277 (77.8) 0.149
No 34 (14.2) 205 (85.8) 56 (17.7) 260 (82.3)
Exercise (sessions/week)
None or <3 61 (12.5) 427 (87.5) 0.070 104 (20.0) 415 (80.0) 0.952
≥3 21 (19.1) 89 (80.9) 31 (20.3) 122 (79.7)
Data are summarized as a mean±SD or n (%).4
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A comparison of clinical characteristics between the 
subjects with insulin resistance and without insulin 
resistance 
BMI, waist circumference, total cholesterol, total cholesterol 
to high-density lipoprotein cholesterol ratio, fasting glucose, 
fasting insulin, and HOMA-IR were significantly higher in insu-
lin-resistant subjects for both men and women. HDL cholester-
ol was significantly lower in insulin-resistant subjects for both 
men and women. Triglyceride, LDL cholesterol and triglyceride 
to HDL cholesterol ratio were significantly higher in insulin-re-
sistant subjects only for women (Table 2).
A comparison of metabolic syndrome and its 
components between insulin-resistant subjects and 
others by gender
A comparison was made for the prevalence of metabolic syn-
drome and its components (modified NCEP-ATP III criteria) by 
gender. The prevalence of metabolic syndrome was about three 
times higher for men and over two times higher for women in 
the insulin-resistant subjects compared to the non-insulin-resis-
tant subjects. Of various categories of metabolic syndrome, high 
waist circumference, high triglycerides, and high fasting plasma 
glucose showed a significantly higher prevalence in the insulin-
resistant subjects in both genders (Table 3).
Table 2. Clinical characteristics of the subjects with insulin resistance and without insulin resistance by gender 
Variables
Men Women
With insulin resistance 
(n=82)
Without insulin  
resistance (n=516) p
With insulin resistance 
(n=135)
Without insulin  
resistance (n=537) p
Body mass index (kg/m
2) 23.3±1.3 22.4±1.7 <0.001 23.1±1.4 22.6±1.6 0.001
Waist circumference (cm)  85.0±6.0 80.9±6.3 <0.001 78.0±5.7 75.9±6.1 0.001
Total cholesterol (mg/dL) 197.9±36.4 186.0±35.7 0.005 204.2±34.4 192.8±34.5 0.001
Triglycerides (mg/dL) 171.0 (63.0-372.0) 122.0 (52.0-375.0) 0.083 132.0 (56.0-369.0) 100.0 (46.0-244.0) <0.001
HDL cholesterol (mg/dL) 51.8±12.3 55.2±14.7 0.026 52.1±12.1 56.0±12.7 0.002
LDL cholesterol (mg/dL) 110.2±33.6 102.1±35.1 0.056 121.6±30.8 113.7±30.9 0.009
Total cholesterol/HDL cholesterol 4.0±1.1 3.6±1.0 0.001 4.1±1.0 3.6±0.9 <0.001
Triglycerides/HDL cholesterol 3.8±2.4 3.2±3.3 0.061 3.6±3.1 2.3±1.8 <0.001
Systolic blood pressure (mmHg) 126.8±15.6 125.2±12.4 0.363 125.5±12.7 123.1±13.1 0.053
Diastolic blood pressure (mmHg) 80.6±8.9 79.9±8.0 0.448 79.3±8.1 78.4±8.3 0.241
Fasting glucose (mg/dL) 98.0 (84.0-220.0) 88.0 (73.0-111.0) <0.001 92.0 (78.0-152.0) 86.0 (76.0-101.0) <0.001
Fasting insulin (mg/dL) 9.3 (6.3-22.7) 3.4 (1.1-6.8) <0.001 9.4 (7.1-20.4) 4.4 (1.8-7.4) <0.001
HOMA-IR 2.3 (1.7-6.2) 0.7 (0.2-1. 6) <0.001 2.1 (1.7-5.7) 1.0 (0.4-1.6) <0.001
Data are summarized as a mean±SD, a median (5-95%) or n (%). 
HDL high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, ho  meostasis model assessment of insulin resistance. 
Table 3. Comparison of metabolic syndrome and its components between the subjects with insulin resistance and without insulin resistance 
by gender
Variables
Men Women
With insulin 
resistance (n=82)
Without insulin resis-
tance (n=516)
p
With insulin 
resistance (n=135)
Without insulin resis-
tance (n=537)
p
E  levated waist circumference (≥90 cm  
for men and ≥85 cm for women)
16 (19.5) 35 (6.8) 0.001 45 (33.3) 122 (22.7) 0.011
Elevated triglycerides (≥150 mg/dL) 47 (57.3) 194 (37.6) 0.001 61 (45.2) 124 (23.1) <0.001
R  educed HDL cholesterol (<40 mg/dL  
for men and <50 mg/dL for women)
13 (15.9) 63 (12.2) 0.357 59 (43.7) 196 (36.5) 0.123
Elevated blood pressure* 42 (51.2) 254 (49.2) 0.737 66 (48.9) 228 (42.5) 0.178
Elevated fasting glucose
† 37 (45.1) 77 (14.9) <0.001 39 (28.9) 38 (7.1) <0.001
Metabolic syndrome
‡ 24 (29.3) 53 (10.3) <0.001 46 (34.1) 84 (15.6) <0.001
Data are summarized as N (%). 
HDL, high-density lipoprotein.
*Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or antihypertensive medication of previously diagnosed hypertension; 
†Fasting 
plasma glucose ≥100 mg/dL or antidiabetic treatment; 
‡modified NCEP-ATP III definition.5
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Factors associated with insulin resistance in the  
non-obese population
After being controlled for all other covariates, the association 
between insulin resistance and BMI was statistically significant 
in the category of 23.0-24.9 kg/m
2 in men (adjusted OR, 4.63; 
95% confidence interval [95% CI], 1.77-12.15) using the cate-
gory of 18.5-20.9 kg/m
2 as a reference. The association between 
insulin resistance and abdominal obesity was statistically signifi-
cant only for men (adjusted OR, 2.57; 95% CI, 1.29-5.11) (Ta-
ble 4).
DISCUSSION
In the present study, we demonstrated that high BMI and ab-
dominal obesity were associated with insulin resistance in non-
obese middle-aged men living in rural areas. Insulin resistance 
was also associated with higher prevalence of metabolic syn-
drome and its components such as elevated waist circumference 
and elevated triglyceride in both genders. It is well known that 
insulin resistance increases the risk for type 2 diabetes and car-
diovascular disease, even for those within the normal BMI range 
[11]. This finding could be more significant in Asians who are 
generally less obese but have more body fat than Caucasians, 
which renders them to have more obesity-related risks for car-
diovascular diseases with similar BMI [21].
Waist circumference was found to be significantly higher in 
insulin-resistant subjects not only according to the criteria of 
abdominal obesity based on the Korean Society for the Study 
of Obesity, but also the criteria of abdominal obesity based on 
the Asia-Pacific diagnostic criteria of male ≥90 cm and female 
≥80 cm [22]. Central obesity has been mentioned as one of 
the major characteristics observed in the MONW group [12], 
and it has also been known to be correlated with insulin resis-
tance [23,24]. The relationship between central obesity and in-
sulin resistance could be explained based on the metabolism of 
free fatty acids or other adipocytokines (TNF-α, IL-6, adiponec-
tin) released from the visceral fat [25]. The abdominal obesity 
and visceral fat were reportedly increased in insulin-resistant 
subjects [9].
We noted that high BMI and abdominal obesity were associ-
ated with insulin resistance only in non-obese men. This gender-
specific discrepancy in the development of metabolic abnormal-
ities has been explained by sex differences in associations be-
tween inflammatory markers [26] and endogenous sex hormo-
nes [27] based on the data from Caucasian studies. However, 
well-designed prospective cohort studies are warranted to elu-
cidate this phenomenon in non-obese Asians.
In this study, we found that metabolic syndrome, a potent risk 
factor for cardiovascular disease [28], had a prevalence that was 
more than two times higher in insulin-resistant subjects. In ad-
dition to elevated waist circumference, it was typically observed 
that elevated triglyceride was significantly higher in insulin-re-
sistant subjects in both genders. In the previous studies conduct-
ed in western countries [29,30] cholesterol level was significant-
ly higher in insulin-resistant subjects. On the other hand, a study 
of non-diabetic Korean adults shows that insulin resistance was 
associated with high triglycerides [31]. In addition, a Japanese 
study shows that triglyceride level was uniquely higher in insu-
lin-resistant subjects, suggesting that the increased level of tri-
Table 4. Factors associated with insulin resistance by gender 
Variables
Men (n=598) Women (n=672)
Adjusted OR* (95% CI) Adjusted OR* (95% CI)
Age  1.00 (0.97-1.04) 1.01 (0.99-1.05)
BMI (kg/m
2) 18.5-20.9 1.00 1.00
21.0-22.9 2.56 (0.94-7.00) 1.35 (0.69-2.66)
23.0-24.9 4.63 (1.77-12.15) 1.89 (0.98-3.56)
High waist circumference  Men <90 cm, Women <85 cm 1.00 1.00
Men ≥90 cm, Women ≥85 cm 2.57 (1.29-5.11) 1.43 (0.92-2.22)
Education  <9 1.00 1.00
≥10 1.54 (0.90-2.64) 0.81 (0.44-1.50)
Occupation Others 1.00 1.00
Farmer 1.31 (0.71-2.41) 0.63 (0.42-1.03)
Drinking alcohol  Non-drinker 1.00 1.00
Ever-drinker 0.71 (0.42-1.19) 0.78 (0.49-1.24)
Balanced diet  No 1.00 1.00
Yes 0.93 (0.57-1.55) 1.41 (0.92-2.22)
Exercise (sessions/week) None or <3 1.00 1.00
≥3 1.49 (0.83-2.67) 0.96 (0.60-1.53)
BMI, body mass index; OR, odds ratio; CI, confidence interval.
*Odds ratio adjusted by all other covariates in each variable.6
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glyceride would play a role in association with insulin resistance 
in the non-obese Asian people [10]. 
In the current study, to define insulin-resistant subjects, an in-
sulin resistance was assessed with the application of HOMA-IR. 
This was used to presume the functions of beta cells as well as 
insulin sensitivity through fasting insulin and fasting glucose. It 
is also known to be highly correlated with insulin resistance 
measured with the hyperinsulinaemic clamp method [18]. Ac-
cordingly, it has widely been used as a tool for measuring insu-
lin resistance in a large-scale community-based epidemiological 
study. Other methods to define the insulin resistance include 
measuring visceral fat areas [32,33] and using NCEP-ATP III 
metabolic syndrome diagnostic criteria [11,34]. Despite the dif-
ferences in defining insulin resistance observed in each study, in 
regard to the characteristics of insulin resistant subjects, consis-
tent results have been mostly proposed [9].
The current study has limitations that should be considered. 
The areas of visceral fat were not measured although they were 
a valid estimator of the abdominal obesity, which was mention-
ed as one of the major characteristics of the non-obese group 
with an insulin resistance. Due to a cross-sectional design, the 
current study has difficulty determining the causality in regard 
to the observed relationship between the factors and insulin re-
sistance. In such a condition that there are few Korean studies, 
however, the results of the current study could be considered to 
be significant.
In conclusion, in middle-aged adults who were apparently non-
obese, insulin resistance defined by highest quartile of HOMA-
IR was associated with high BMI and abdominal obesity for 
men. Further prospective studies are warranted to clarify risk 
factors, which is essential for detecting insulin resistant subjects 
and performing the appropriate interventions for them.
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